ProShares Ultra Nasdaq Biotechnology Holdings
BIB was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.
Last Updated: 5 days, 22 hours ago
Last reported holdings - ProShares Ultra Nasdaq Biotechnology
| Ticker | Name | Est. Value |
|---|---|---|
|
None
|
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | $17.5 million |
|
None
|
NASDAQ BIO INDEX SWAP BNP PARIBAS | $17.5 million |
|
None
|
NET OTHER ASSETS (LIABILITIES) | $15.4 million |
|
None
|
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | $13.7 million |
|
None
|
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | $9.2 million |
|
None
|
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | $9.1 million |
|
None
|
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | $9.0 million |
|
B 0 10.09.25
|
TREASURY BILL | $5.0 million |
|
WIB 0 10.09.25
|
TREASURY BILL | $5.0 million |
|
GILD
|
GILEAD SCIENCES INC | $2.5 million |
|
AMGN
|
AMGEN INC | $2.4 million |
|
VRTX
|
VERTEX PHARMACEUTICALS INC | $2.2 million |
|
REGN
|
REGENERON PHARMACEUTICALS | $2.1 million |
|
ALNY
|
ALNYLAM PHARMACEUTICALS INC | $1.8 million |
|
AZN
|
ASTRAZENECA PLC-SPONS ADR | $1.7 million |
|
INSM
|
INSMED INC | $912619 |
|
ARGX
|
ARGENX SE - ADR | $812895 |
|
BIIB
|
BIOGEN INC | $720691 |
|
SMMT
|
SUMMIT THERAPEUTICS INC | $621227 |
|
UTHR
|
UNITED THERAPEUTICS CORP | $602664 |
|
INCY
|
INCYTE CORP | $581162 |
|
RPRX
|
ROYALTY PHARMA PLC- CL A | $546452 |
|
ILMN
|
ILLUMINA INC | $543393 |
|
NBIX
|
NEUROCRINE BIOSCIENCES INC | $488451 |
|
MEDP
|
MEDPACE HOLDINGS INC | $487645 |
|
ONC
|
BEONE MEDICINES LTD-ADR | $463114 |
|
TEM
|
TEMPUS AI INC | $461532 |
|
SNY
|
SANOFI-ADR | $448359 |
|
VTRS
|
VIATRIS INC | $426133 |
|
ASND
|
ASCENDIS PHARMA A/S - ADR | $422809 |
|
BMRN
|
BIOMARIN PHARMACEUTICAL INC | $382438 |
|
BNTX
|
BIONTECH SE-ADR | $363285 |
|
EXEL
|
EXELIXIS INC | $358249 |
|
BBIO
|
BRIDGEBIO PHARMA INC | $345809 |
|
MDGL
|
MADRIGAL PHARMACEUTICALS INC | $335912 |
|
IONS
|
IONIS PHARMACEUTICALS INC | $332063 |
|
MRNA
|
MODERNA INC | $330038 |
|
HALO
|
HALOZYME THERAPEUTICS INC | $317822 |
|
ROIV
|
ROIVANT SCIENCES LTD | $300347 |
|
VRNA
|
VERONA PHARMA PLC - ADR | $293541 |
|
JAZZ
|
JAZZ PHARMACEUTICALS PLC | $277419 |
|
GH
|
GUARDANT HEALTH INC | $267222 |
|
RVMD
|
REVOLUTION MEDICINES INC | $254927 |
|
RYTM
|
RHYTHM PHARMACEUTICALS INC | $233818 |
|
AXSM
|
AXSOME THERAPEUTICS INC | $215229 |
|
CYTK
|
CYTOKINETICS INC | $208751 |
|
RNA
|
AVIDITY BIOSCIENCES INC | $205415 |
|
NUVL
|
NUVALENT INC-A | $185710 |
|
ALKS
|
ALKERMES PLC | $167793 |
|
PTCT
|
PTC THERAPEUTICS INC | $161557 |
|
MRUS
|
MERUS NV | $161203 |
|
CRSP
|
CRISPR THERAPEUTICS AG | $160065 |
|
KRYS
|
KRYSTAL BIOTECH INC | $152295 |
|
ACAD
|
ACADIA PHARMACEUTICALS INC | $149991 |
|
PCVX
|
VAXCYTE INC | $145800 |
|
ADMA
|
ADMA BIOLOGICS INC | $141866 |
|
ACLX
|
ARCELLX INC | $139846 |
|
ARWR
|
ARROWHEAD PHARMACEUTICALS IN | $135940 |
|
PTGX
|
PROTAGONIST THERAPEUTICS INC | $129868 |
|
MIRM
|
MIRUM PHARMACEUTICALS INC | $129147 |
|
APLS
|
APELLIS PHARMACEUTICALS INC | $126575 |
|
AKRO
|
AKERO THERAPEUTICS INC | $123416 |
|
LGND
|
LIGAND PHARMACEUTICALS | $113727 |
|
CRNX
|
CRINETICS PHARMACEUTICALS IN | $112785 |
|
INDV
|
INDIVIOR PLC | $108416 |
|
SRRK
|
SCHOLAR ROCK HOLDING CORP | $108219 |
|
AMRX
|
AMNEAL PHARMACEUTICALS INC | $105183 |
|
XENE
|
XENON PHARMACEUTICALS INC | $104289 |
|
RARE
|
ULTRAGENYX PHARMACEUTICAL IN | $103880 |
|
NAMS
|
NEWAMSTERDAM PHARMA CO NV | $101203 |
|
LEGN
|
LEGEND BIOTECH CORP-ADR | $100491 |
|
IMVT
|
IMMUNOVANT INC | $96832 |
|
KYMR
|
KYMERA THERAPEUTICS INC | $96553 |
|
SUPN
|
SUPERNUS PHARMACEUTICALS INC | $89360 |
|
FOLD
|
AMICUS THERAPEUTICS INC | $86816 |
|
VCYT
|
VERACYTE INC | $86806 |
|
TARS
|
TARSUS PHARMACEUTICALS INC | $84766 |
|
CGON
|
CG ONCOLOGY INC | $82919 |
|
IDYA
|
IDEAYA BIOSCIENCES INC | $79478 |
|
MLYS
|
MINERALYS THERAPEUTICS INC | $75844 |
|
DNLI
|
DENALI THERAPEUTICS INC | $75591 |
|
ALVO
|
ALVOTECH SA | $75407 |
|
IBRX
|
IMMUNITYBIO INC | $74142 |
|
AGIO
|
AGIOS PHARMACEUTICALS INC | $73524 |
|
IRON
|
DISC MEDICINE INC | $73191 |
|
HRMY
|
HARMONY BIOSCIENCES HOLDINGS | $73180 |
|
ANIP
|
ANI PHARMACEUTICALS INC | $73152 |
|
OCUL
|
OCULAR THERAPEUTIX INC | $71120 |
|
ADPT
|
ADAPTIVE BIOTECHNOLOGIES | $69526 |
|
ARQT
|
ARCUTIS BIOTHERAPEUTICS INC | $67887 |
|
TVTX
|
TRAVERE THERAPEUTICS INC | $66051 |
|
BEAM
|
BEAM THERAPEUTICS INC | $65557 |
|
SRPT
|
SAREPTA THERAPEUTICS INC | $63742 |
|
RXRX
|
RECURSION PHARMACEUTICALS-A | $63501 |
|
ZLAB
|
ZAI LAB LTD-ADR | $61020 |
|
BCRX
|
BIOCRYST PHARMACEUTICALS INC | $60809 |
|
APGE
|
APOGEE THERAPEUTICS INC | $60002 |
|
VCEL
|
VERICEL CORP | $59528 |
|
AUPH
|
AURINIA PHARMACEUTICALS INC | $59479 |
|
MNKD
|
MANNKIND CORP | $57047 |
|
ARDX
|
ARDELYX INC | $55233 |
|
EWTX
|
EDGEWISE THERAPEUTICS INC | $54006 |
|
TWST
|
TWIST BIOSCIENCE CORP | $53976 |
|
CNTA
|
CENTESSA PHARMACEUTICALS-ADR | $53007 |
|
TXG
|
10X GENOMICS INC-CLASS A | $52977 |
|
DYN
|
DYNE THERAPEUTICS INC | $52920 |
|
KNSA
|
KINIKSA PHARMACEUTICALS INTE | $52838 |
|
COGT
|
COGENT BIOSCIENCES INC | $51811 |
|
AVDL
|
AVADEL PHARMACEUTICALS | $50951 |
|
JANX
|
JANUX THERAPEUTICS INC | $49747 |
|
IMCR
|
IMMUNOCORE HOLDINGS PLC-ADR | $49187 |
|
VERA
|
VERA THERAPEUTICS INC | $49099 |
|
SNDX
|
SYNDAX PHARMACEUTICALS INC | $48942 |
|
AMPH
|
AMPHASTAR PHARMACEUTICALS IN | $48338 |
|
PGEN
|
PRECIGEN INC | $47314 |
|
NVCR
|
NOVOCURE LTD | $46949 |
|
HROW
|
HARROW INC | $46661 |
|
INVA
|
INNOVIVA INC | $46128 |
|
XERS
|
XERIS BIOPHARMA HOLDINGS INC | $44404 |
|
COLL
|
COLLEGIUM PHARMACEUTICAL INC | $44369 |
|
NVAX
|
NOVAVAX INC | $44340 |
|
WVE
|
WAVE LIFE SCIENCES LTD | $44327 |
|
ETNB
|
89BIO INC | $44169 |
|
ABCL
|
ABCELLERA BIOLOGICS INC | $43642 |
|
PCRX
|
PACIRA BIOSCIENCES INC | $43516 |
|
GRAL
|
GRAIL INC | $42524 |
|
GRFS
|
GRIFOLS SA-ADR | $42451 |
|
CVAC
|
CUREVAC NV | $42329 |
|
NTLA
|
INTELLIA THERAPEUTICS INC | $42273 |
|
DVAX
|
DYNAVAX TECHNOLOGIES CORP | $42125 |
|
GPCR
|
STRUCTURE THERAPEUTICS INC | $41357 |
|
GMAB
|
GENMAB A/S -SP ADR | $40330 |
|
LENZ
|
LENZ THERAPEUTICS INC | $39480 |
|
STOK
|
STOKE THERAPEUTICS INC | $37669 |
|
SPRY
|
ARS PHARMACEUTICALS INC | $36891 |
|
SYRE
|
SPYRE THERAPEUTICS INC | $36052 |
|
ZYME
|
ZYMEWORKS INC | $34510 |
|
ELVN
|
ENLIVEN THERAPEUTICS INC | $34497 |
|
QURE
|
UNIQURE NV | $34112 |
|
FTRE
|
FORTREA HOLDINGS INC | $33442 |
|
PRAX
|
PRAXIS PRECISION MEDICINES I | $32908 |
|
AMLX
|
AMYLYX PHARMACEUTICALS INC | $31193 |
|
GERN
|
GERON CORP | $30892 |
|
CRMD
|
CORMEDIX INC | $30540 |
|
URGN
|
UROGEN PHARMA LTD | $30474 |
|
TSHA
|
TAYSHA GENE THERAPIES INC | $29910 |
|
PHAT
|
PHATHOM PHARMACEUTICALS INC | $29424 |
|
EYPT
|
EYEPOINT PHARMACEUTICALS INC | $28737 |
|
AVXL
|
ANAVEX LIFE SCIENCES CORP | $28098 |
|
PAHC
|
PHIBRO ANIMAL HEALTH CORP-A | $27895 |
|
ABUS
|
ARBUTUS BIOPHARMA CORP | $27003 |
|
ORIC
|
ORIC PHARMACEUTICALS INC | $26925 |
|
KALV
|
KALVISTA PHARMACEUTICALS INC | $26569 |
|
DAWN
|
DAY ONE BIOPHARMACEUTICALS I | $26409 |
|
TNGX
|
TANGO THERAPEUTICS INC | $26029 |
|
TRVI
|
TREVI THERAPEUTICS INC | $25847 |
|
IOVA
|
IOVANCE BIOTHERAPEUTICS INC | $25823 |
|
RIGL
|
RIGEL PHARMACEUTICALS INC | $25241 |
|
VIR
|
VIR BIOTECHNOLOGY INC | $24980 |
|
KURA
|
KURA ONCOLOGY INC | $24739 |
|
TBPH
|
THERAVANCE BIOPHARMA INC | $24713 |
|
MNMD
|
MIND MEDICINE MINDMED INC | $24505 |
|
NRIX
|
NURIX THERAPEUTICS INC | $24441 |
|
RLAY
|
RELAY THERAPEUTICS INC | $24104 |
|
SANA
|
SANA BIOTECHNOLOGY INC | $23622 |
|
AVBP
|
ARRIVENT BIOPHARMA INC | $23502 |
|
CSTL
|
CASTLE BIOSCIENCES INC | $23459 |
|
TYRA
|
TYRA BIOSCIENCES INC | $22701 |
|
TRML
|
TOURMALINE BIO INC | $22615 |
|
KROS
|
KEROS THERAPEUTICS INC | $22205 |
|
MGTX
|
MEIRAGTX HOLDINGS PLC | $21793 |
|
SVRA
|
SAVARA INC | $21744 |
|
ANAB
|
ANAPTYSBIO INC | $21743 |
|
TERN
|
TERNS PHARMACEUTICALS INC | $21688 |
|
MESO
|
MESOBLAST LTD- SPON ADR | $21577 |
|
SIGA
|
SIGA TECHNOLOGIES INC | $21335 |
|
XNCR
|
XENCOR INC | $20950 |
|
ORKA
|
ORUKA THERAPEUTICS INC | $19715 |
|
RAPP
|
RAPPORT THERAPEUTICS INC | $19678 |
|
ARVN
|
ARVINAS INC | $19534 |
|
AQST
|
AQUESTIVE THERAPEUTICS INC | $17669 |
|
ESPR
|
ESPERION THERAPEUTICS INC | $17626 |
|
ZVRA
|
ZEVRA THERAPEUTICS INC | $17163 |
|
EOLS
|
EVOLUS INC | $17002 |
|
GLPG
|
GALAPAGOS NV-SPON ADR | $16657 |
|
RGNX
|
REGENXBIO INC | $16626 |
|
CMPS
|
COMPASS PATHWAYS PLC | $16279 |
|
HCM
|
HUTCHMED CHINA-ADR | $16145 |
|
ARCT
|
ARCTURUS THERAPEUTICS HOLDIN | $16005 |
|
PSNL
|
PERSONALIS INC | $15804 |
|
REPL
|
REPLIMUNE GROUP INC | $15733 |
|
PRME
|
PRIME MEDICINE INC | $15694 |
|
PRTA
|
PROTHENA CORP PLC | $15549 |
|
CRVS
|
CORVUS PHARMACEUTICALS INC | $15522 |
|
ALMS
|
ALUMIS INC | $15456 |
|
OLMA
|
OLEMA PHARMACEUTICALS INC | $15265 |
|
SLDB
|
SOLID BIOSCIENCES INC | $15145 |
|
ERAS
|
ERASCA INC | $14739 |
|
CGEM
|
CULLINAN THERAPEUTICS INC | $14365 |
|
INBX
|
INHIBRX BIOSCIENCES INC | $14137 |
|
AURA
|
AURA BIOSCIENCES INC | $13995 |
|
ATXS
|
ASTRIA THERAPEUTICS INC | $13881 |
|
LXRX
|
LEXICON PHARMACEUTICALS INC | $13657 |
|
YMAB
|
Y-MABS THERAPEUTICS INC | $13634 |
|
PACB
|
PACIFIC BIOSCIENCES OF CALIF | $13078 |
|
RCKT
|
ROCKET PHARMACEUTICALS INC | $12232 |
|
DSGN
|
DESIGN THERAPEUTICS INC | $12195 |
|
MRVI
|
MARAVAI LIFESCIENCES HLDGS-A | $11939 |
|
TECX
|
TECTONIC THERAPEUTIC INC | $11311 |
|
BCYC
|
BICYCLE THERAPEUTICS PLC-ADR | $10810 |
|
FDMT
|
4D MOLECULAR THERAPEUTICS IN | $10767 |
|
ABSI
|
ABSCI CORP | $10761 |
|
GLUE
|
MONTE ROSA THERAPEUTICS INC | $10610 |
|
AMRN
|
AMARIN CORP PLC -ADR | $10596 |
|
FHTX
|
FOGHORN THERAPEUTICS INC | $10548 |
|
SCPH
|
SCPHARMACEUTICALS INC | $10350 |
|
AUTL
|
AUTOLUS THERAPEUTICS PLC | $10216 |
|
ALT
|
ALTIMMUNE INC | $10149 |
|
AVIR
|
ATEA PHARMACEUTICALS INC | $10023 |
|
ALEC
|
ALECTOR INC | $9906 |
|
NGNE
|
NEUROGENE INC | $9844 |
|
VNDA
|
VANDA PHARMACEUTICALS INC | $9618 |
|
NMRA
|
NEUMORA THERAPEUTICS INC | $9264 |
|
RNAC
|
CARTESIAN THERAPEUTICS INC | $9110 |
|
LRMR
|
LARIMAR THERAPEUTICS INC | $8715 |
|
SLN
|
SILENCE THERAPEUTICS PLC-ADR | $8639 |
|
OMER
|
OMEROS CORP | $8610 |
|
ALLO
|
ALLOGENE THERAPEUTICS INC | $8533 |
|
ANNX
|
ANNEXON INC | $8292 |
|
TKNO
|
ALPHA TEKNOVA INC | $7966 |
|
HUMA
|
HUMACYTE INC | $7959 |
|
ACIU
|
AC IMMUNE SA | $7587 |
|
VYGR
|
VOYAGER THERAPEUTICS INC | $7550 |
|
EDIT
|
EDITAS MEDICINE INC | $7418 |
|
CDXS
|
CODEXIS INC | $7047 |
|
TRDA
|
ENTRADA THERAPEUTICS INC | $6963 |
|
OABI
|
OMNIAB INC | $6881 |
|
ENTA
|
ENANTA PHARMACEUTICALS INC | $6685 |
|
CCCC
|
C4 THERAPEUTICS INC | $6666 |
|
IRWD
|
IRONWOOD PHARMACEUTICALS INC | $6254 |
|
LYEL
|
LYELL IMMUNOPHARMA INC | $6094 |
|
LXEO
|
LEXEO THERAPEUTICS INC | $5795 |
|
TVGN
|
TEVOGEN BIO HOLDINGS INC | $5683 |
|
CLYM
|
CLIMB BIO INC | $5536 |
|
KYTX
|
KYVERNA THERAPEUTICS INC | $5521 |
|
NKTX
|
NKARTA INC | $5314 |
|
MXCT
|
MAXCYTE INC | $5083 |
|
MGNX
|
MACROGENICS INC | $4299 |
|
FATE
|
FATE THERAPEUTICS INC | $3919 |
|
PLRX
|
PLIANT THERAPEUTICS INC | $3515 |
|
PYXS
|
PYXIS ONCOLOGY INC | $3506 |
|
TCRX
|
TSCAN THERAPEUTICS INC | $3471 |
|
STRO
|
SUTRO BIOPHARMA INC | $3027 |
|
ARTV
|
ARTIVA BIOTHERAPEUTICS INC | $2662 |
|
BMEA
|
BIOMEA FUSION INC | $2419 |
|
APLT
|
APPLIED THERAPEUTICS INC | $2315 |
|
PEPG
|
PEPGEN INC | $1469 |
|
ACRV
|
ACRIVON THERAPEUTICS INC | $1431 |
|
MRSN
|
MERSANA THERAPEUTICS INC | $1246 |
|
OKUR
|
ONKURE THERAPEUTICS INC-A | $1215 |
|
QTTB
|
Q32 BIO INC | $710 |
|
2324462D
|
CARTESIAN THERAPEUTICS-CVR | $0 |
|
THRD
|
THIRD HARMONIC BIO INC | $0 |
Recent Changes - ProShares Ultra Nasdaq Biotechnology
| Date | Ticker | Name | Change (Shares) |
|---|---|---|---|
| 2025-09-03 |
MRSN
|
Mersana Therapeutics Inc | -175 |
| 2025-09-03 |
QTTB
|
Q32 Bio Inc | -428 |
| 2025-09-03 |
ARTV
|
Artiva Biotherapeutics Inc | -856 |
| 2025-09-03 |
ACRV
|
Acrivon Therapeutics Inc | -1,101 |
| 2025-09-03 |
PEPG
|
PepGen Inc | -1,148 |
| 2025-09-03 |
APLT
|
Applied Therapeutics Inc | -4,977 |
| 2025-09-03 |
BMEA
|
Biomea Fusion Inc | -1,322 |
| 2025-09-03 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-09-03 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -452 |
| 2025-09-02 |
MRSN
|
Mersana Therapeutics Inc | -175 |
| 2025-09-02 |
QTTB
|
Q32 Bio Inc | -428 |
| 2025-09-02 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-09-02 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -452 |
| 2025-09-02 |
ACRV
|
Acrivon Therapeutics Inc | -1,101 |
| 2025-09-02 |
BMEA
|
Biomea Fusion Inc | -1,322 |
| 2025-09-02 |
APLT
|
Applied Therapeutics Inc | -4,977 |
| 2025-09-02 |
PEPG
|
PepGen Inc | -1,148 |
| 2025-09-02 |
ARTV
|
Artiva Biotherapeutics Inc | -856 |
| 2025-08-29 |
BMEA
|
Biomea Fusion Inc | -1,322 |
| 2025-08-29 |
QTTB
|
Q32 Bio Inc | -428 |
| 2025-08-29 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -452 |
| 2025-08-29 |
ITOS
|
ITeos Therapeutics Inc Ordinary Shares | -1,344 |
| 2025-08-29 |
ACRV
|
Acrivon Therapeutics Inc | -1,101 |
| 2025-08-29 |
PEPG
|
PepGen Inc | -1,148 |
| 2025-08-29 |
MRSN
|
Mersana Therapeutics Inc | -175 |
| 2025-08-29 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-29 |
APLT
|
Applied Therapeutics Inc | -4,977 |
| 2025-08-29 |
STRO
|
Sutro Biopharma Inc | -2,968 |
| 2025-08-27 |
BMEA
|
Biomea Fusion Inc | -1,322 |
| 2025-08-27 |
QTTB
|
Q32 Bio Inc | -428 |
| 2025-08-27 |
HCM
|
HUTCHMED (China) Ltd ADR | -1,088 |
| 2025-08-27 |
MRSN
|
Mersana Therapeutics Inc | -175 |
| 2025-08-27 |
HCM
|
HUTCHMED CHINA-ADR | 1,088 |
| 2025-08-27 |
PEPG
|
PepGen Inc | -1,148 |
| 2025-08-27 |
ACRV
|
Acrivon Therapeutics Inc | -1,101 |
| 2025-08-27 |
APLT
|
Applied Therapeutics Inc | -4,977 |
| 2025-08-27 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -452 |
| 2025-08-27 |
STRO
|
Sutro Biopharma Inc | -2,968 |
| 2025-08-27 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-26 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -452 |
| 2025-08-26 |
MRSN
|
Mersana Therapeutics Inc | -175 |
| 2025-08-26 |
ACRV
|
Acrivon Therapeutics Inc | -1,101 |
| 2025-08-26 |
PEPG
|
PepGen Inc | -1,148 |
| 2025-08-26 |
QTTB
|
Q32 Bio Inc | -428 |
| 2025-08-26 |
BMEA
|
Biomea Fusion Inc | -1,322 |
| 2025-08-26 |
ARTV
|
Artiva Biotherapeutics Inc | -856 |
| 2025-08-26 |
STRO
|
Sutro Biopharma Inc | -2,968 |
| 2025-08-26 |
WIB 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-26 |
APLT
|
Applied Therapeutics Inc | -4,977 |
| 2025-08-25 |
PEPG
|
PepGen Inc | -1,205 |
| 2025-08-25 |
BMEA
|
Biomea Fusion Inc | -1,385 |
| 2025-08-25 |
ACRV
|
Acrivon Therapeutics Inc | -1,155 |
| 2025-08-25 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-25 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -473 |
| 2025-08-25 |
ARTV
|
Artiva Biotherapeutics Inc | -898 |
| 2025-08-25 |
QTTB
|
Q32 Bio Inc | -449 |
| 2025-08-25 |
APLT
|
Applied Therapeutics Inc | -5,217 |
| 2025-08-25 |
STRO
|
Sutro Biopharma Inc | -3,112 |
| 2025-08-25 |
MRSN
|
Mersana Therapeutics Inc | -184 |
| 2025-08-22 |
STRO
|
Sutro Biopharma Inc | -3,112 |
| 2025-08-22 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -473 |
| 2025-08-22 |
PEPG
|
PepGen Inc | -1,205 |
| 2025-08-22 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -544 |
| 2025-08-22 |
MRSN
|
Mersana Therapeutics Inc | -184 |
| 2025-08-22 |
QTTB
|
Q32 Bio Inc | -449 |
| 2025-08-22 |
ACRV
|
Acrivon Therapeutics Inc | -1,155 |
| 2025-08-22 |
BMEA
|
Biomea Fusion Inc | -1,385 |
| 2025-08-22 |
ARTV
|
Artiva Biotherapeutics Inc | -898 |
| 2025-08-22 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-22 |
LYEL
|
LYELL IMMUNOPHARMA INC | 520 |
| 2025-08-22 |
APLT
|
Applied Therapeutics Inc | -5,217 |
| 2025-08-21 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -473 |
| 2025-08-21 |
ACRV
|
Acrivon Therapeutics Inc | -1,155 |
| 2025-08-21 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-21 |
APLT
|
Applied Therapeutics Inc | -5,217 |
| 2025-08-21 |
MRSN
|
Mersana Therapeutics Inc | -184 |
| 2025-08-21 |
PEPG
|
PepGen Inc | -1,205 |
| 2025-08-21 |
STRO
|
Sutro Biopharma Inc | -3,112 |
| 2025-08-21 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -544 |
| 2025-08-21 |
LYEL
|
LYELL IMMUNOPHARMA INC | 544 |
| 2025-08-21 |
BMEA
|
Biomea Fusion Inc | -1,385 |
| 2025-08-21 |
ARTV
|
Artiva Biotherapeutics Inc | -898 |
| 2025-08-21 |
QTTB
|
Q32 Bio Inc | -449 |
| 2025-08-20 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-20 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-20 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-20 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-20 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-20 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-20 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-20 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-20 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-20 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-20 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-19 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-19 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-19 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-19 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-19 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-19 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-19 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-19 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-19 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-19 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-19 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-19 |
LYEL
|
LYELL IMMUNOPHARMA INC | 544 |
| 2025-08-19 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-18 |
CRGX
|
Cargo Therapeutics Inc | -1,725 |
| 2025-08-18 |
LYEL
|
LYELL IMMUNOPHARMA INC | 552 |
| 2025-08-18 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-18 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-18 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-18 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-18 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-18 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-18 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-18 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-18 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-15 |
CRGX
|
Cargo Therapeutics Inc | -1,725 |
| 2025-08-15 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-15 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-15 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-15 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-15 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-15 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-15 |
LYEL
|
LYELL IMMUNOPHARMA INC | 552 |
| 2025-08-15 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-15 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-15 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-15 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-15 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-14 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-14 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-14 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-14 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-14 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-14 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-14 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-14 |
LYEL
|
LYELL IMMUNOPHARMA INC | 552 |
| 2025-08-14 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-14 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-14 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-14 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-14 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-13 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-13 |
LYEL
|
LYELL IMMUNOPHARMA INC | 552 |
| 2025-08-13 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-13 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-13 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-13 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-13 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-13 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-13 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-13 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-13 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-13 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-13 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-12 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-12 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-12 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-12 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-12 |
THRD
|
Third Harmonic Bio Inc | -1,662 |
| 2025-08-12 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-12 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-12 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-12 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-12 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-12 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-12 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-11 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-11 |
LYEL
|
Lyell Immunopharma Inc Ordinary Shares | -552 |
| 2025-08-11 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-11 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-11 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-11 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-11 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-11 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-11 |
LYEL
|
LYELL IMMUNOPHARMA INC | 552 |
| 2025-08-11 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-11 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-11 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-11 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-08 |
STRO
|
Sutro Biopharma Inc | -3,160 |
| 2025-08-08 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-08 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-08 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-08 |
MRSN
|
Mersana Therapeutics Inc | -187 |
| 2025-08-08 |
OKUR
|
OnKure Therapeutics Inc Class A Shares | -480 |
| 2025-08-08 |
QTTB
|
Q32 Bio Inc | -456 |
| 2025-08-08 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-08 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-08 |
ARTV
|
Artiva Biotherapeutics Inc | -912 |
| 2025-08-08 |
B 0 10.09.25
|
United States Treasury Bills 0% | -5.0 million |
| 2025-08-07 |
B 0 08.07.25
|
United States Treasury Bills 0% | -4.0 million |
| 2025-08-07 |
PEPG
|
PepGen Inc | -1,224 |
| 2025-08-07 |
ACRV
|
Acrivon Therapeutics Inc | -1,173 |
| 2025-08-07 |
PYXS
|
Pyxis Oncology Inc | -2,318 |
| 2025-08-07 |
APLT
|
Applied Therapeutics Inc | -5,297 |
| 2025-08-07 |
BMEA
|
Biomea Fusion Inc | -1,406 |
| 2025-08-07 |
MRSN
|
Mersana Therapeutics Inc | -187 |